Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention.

MLA

Yoshihara, Fumiki, et al. “Combined Evaluation of Plasma B-Type Natriuretic Peptide and Urinary Liver-Type Fatty Acid-Binding Protein/Creatinine Ratio Is Related to Worsening Renal Function in Patients Undergoing Elective Percutaneous Coronary Intervention.” Clinical and Experimental Nephrology, vol. 25, no. 12, Dec. 2021, pp. 1319–28. EBSCOhost, https://doi.org/10.1007/s10157-021-02113-9.

APA

Yoshihara, F., Hosoda, H., Doi, T., Yoshida, M., Kitamura, K., Yamamoto, H., Asaumi, Y., Ishibashi-Ueda, H., Kishida, M., Arisato, T., Matsuo, M., Miyazato, M., & Yasuda, S. (2021). Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention. Clinical and Experimental Nephrology, 25(12), 1319–1328. https://doi.org/10.1007/s10157-021-02113-9

Chicago

Yoshihara, Fumiki, Hiroshi Hosoda, Takahito Doi, Morikatsu Yoshida, Kazuo Kitamura, Haruko Yamamoto, Yasuhide Asaumi, et al. 2021. “Combined Evaluation of Plasma B-Type Natriuretic Peptide and Urinary Liver-Type Fatty Acid-Binding Protein/Creatinine Ratio Is Related to Worsening Renal Function in Patients Undergoing Elective Percutaneous Coronary Intervention.” Clinical and Experimental Nephrology 25 (12): 1319–28. doi:10.1007/s10157-021-02113-9.